About Linshom
Linshom is a Healthcare company based in Ellicott City (United States) founded in 2009. Linshom has raised $3.35 million across 9 funding rounds from investors including NIH, HHS and TEDCO. Its chief executive, as recorded, is Richard Hughen. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Monitoring Devices. Its competitors include Apieron, Medipines and Spirosure; 3 of its 3 listed competitors have raised funding.
Company details
Developer of respiratory monitoring devices. The Linshom Respiratory Monitoring Device (LRMD) monitors and displays breaths per minute, seconds since last breath, relative tidal information, respiratory signals, and others. Consists of a disposable sensor, a control unit, and a monitor. Used non-invasively with an oxygen mask or nasal cannula setting.
- Headquarters Ellicott City, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website linshomforlife.com
- Total Equity Funding$3.35M (USD)
in 9 rounds
- Latest Funding Round$400K (USD), Series A
Feb 2024
- InvestorsNIH
& 5 more
Funding Insights of Linshom
Linshom has successfully raised a total of $3.35M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $400 thousand completed in February 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.35M
- Total Rounds 9
- Last Round Series A — $400,000
- Investors Count 6
All 9 funding rounds of Linshom with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2024 | $400,000 | Series A | – | TEDCO | |
| Nov 2023 | $20,000 | Grant | – | – | |
| Aug 2023 | $650,000 | Series A | – | Abell Foundation | |
| Dec 2022 | $300,000 | Seed | – | TEDCO | – |
| Nov 2022 | $2.4M | Grant | – | – | |
| Sep 2022 | $2.67M | Grant | – | – | |
| Jun 2022 | $500,000 | Seed | – | – | – |
| Apr 2022 | $1.5M | Seed | – | Maryland Momentum Fund | – |
| Dec 2017 | Seed | – | TEDCO | – |
6 investors in total: 6 institutional.
Investors in Linshom
Linshom has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and TEDCO.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund and startup accelerator programs focused on seed and early stage companies | 1998 | tedcomd.com | Columbia, United States | |
| lighthouselabsrva.org | ||||
Investment funding is provided for University System of Maryland ventures. | momentum.usmd.edu | United States | ||
Provides grants and investments to support health, education, and community development in Baltimore. | 1953 | abell.org | Baltimore, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Linshom
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Linshom
5 people are tracked at Linshom (2 in leadership, 3 in board & advisors).
| Name | Role | Group |
|---|---|---|
Richard Hughen | CEO | Leadership |
Tomer Feldman | Chief Medical Officer | Leadership |
Ashish K. Khanna | Advisor | Board & advisors |
Jerrold Lerman | Advisor | Board & advisors |
Uri Feldman | Advisor | Board & advisors |
Complete people profiles for Linshom
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Linshom
3 dated milestones of Linshom across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Linshom is founded.
- Funding First funding round.
- Funding Latest funding round, Series A, of $400K.
Competitors of Linshom
Linshom has 3 listed competitors in our database, 3 of them funded. They include Apieron, Medipines and Spirosure.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| apieron.com | 2001 | Menlo Park, United States | $68.52M | Functions as an asthma monitoring device for health management. | ||
| medipines.com | 2014 | Yorba Linda, United States | $2.56M | 10 | Non-invasive respiratory measurement devices are developed for gas exchange assessment. | |
| spirosure.com | 2011 | Pleasanton, United States | $50M | 12 | Non-invasive breathalyzers are developed for pulmonary disease monitoring. |
Detailed competitors of Linshom
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pulmonology
3 companies that operate in the same segment as Linshom (Pulmonology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of novel protein-based therapeutics using machine learning and biological engineering | 2018 | Somerville, Massachusetts, United States | USD 693 M | 329 | ||
Portable oxygen concentrators are supplied for respiratory therapy needs. | 2001 | Goleta, California, United States | USD 51.65 M | USD 348.67 M | 766 | |
Robotic microsurgical systems for endoscopy are developed. | 2007 | Redwood City, California, United States | USD 733.62 M | 91 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Linshom
Complete news archive for Linshom
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Linshom
Linshom was founded in 2009 and raised its 1st funding round 8 years after it was founded.
Linshom is headquartered in Ellicott City, United States. It is registered at Ellicott City, Maryland, United States.
Richard Hughen is the CEO of Linshom, as recorded in our data.
Linshom is a funded company, having raised a total of $3.35M across 9 funding rounds to date.
Developer of respiratory monitoring devices. The Linshom Respiratory Monitoring Device (LRMD) monitors and displays breaths per minute, seconds since last breath, relative tidal information, respiratory signals, and others. Consists of a disposable sensor, a control unit, and a monitor. Used non-invasively with an oxygen mask or nasal cannula setting.
Linshom has 6 investors. Key investors include NIH, HHS, TEDCO, Abell Foundation, and Lighthouse Labs.